Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Transplant ID 101 for the General ID Practitioner

470 - Review of infection prevention strategies for HCT and CAR-T cell therapy recipients

Saturday, October 19, 2024
8:00 AM – 8:30 AM US PT
Location: 403 A

    Speaker(s)

  • Joshua A. Hill, MD

    Associate Professor
    Fred Hutchinson Cancer Center; University of Washington
    Seattle, WA, United States

    Slides
Disclosure(s):
Joshua A. Hill, MD: AlloVir: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Century Therapeutics, Inc: Advisor/Consultant (Terminated, May 31, 2023); CSL Behring: Advisor/Consultant (Ongoing); Deverra: Grant/Research Support (Ongoing); GeoVax: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead Australia: Advisor/Consultant (Terminated, February 28, 2024); Karius: Advisor/Consultant (Ongoing); Merck: Grant/Research Support (Ongoing); Moderna: Board Member (Terminated, January 6, 2024); Modulus: Advisor/Consultant (Ongoing); Oxford Immunotec: Grant/Research Support (Ongoing); Senti BioSciences, Inc: Advisor/Consultant (Ongoing); Takeda: Advisor/Consultant (Terminated, December 31, 2022); Up-to-Date: Advisor/Consultant (Terminated, June 7, 2023)